title: Clinical utility of natriuretic peptides in left ventricular failure.
abstract: Left ventricular failure (LVF) is a clinical syndrome caused by abnormal systolic or diastolic function failing to meet the metabolic requirements of the body. It is important to diagnose and manage LVF in the earliest stages to prevent mortality and morbidity. This article extensively reviews the diagnostic, therapeutic, and prognostic utility of natriuretic peptides in LVF.
authors: Department of Medicine, University of Florida, 653-1 W 8th St, Jacksonville, FL 32209, USA. pramod.reddy@jax.ufl.edu
authors: Pramod
authors: P
authors: Reddy
authors: Rohan
authors: R
authors: Samson
mesh_terms: D015415:Biomarkers / Q000097:blood; D006207:Half-Life; D006333:Heart Failure / Q000097:blood* / Q000175:diagnosis; D006801:Humans; D020097:Natriuretic Peptide, Brain / Q000097:blood* / Q000502:physiology; D011379:Prognosis; D011655:Pulmonary Embolism / Q000097:blood; D051436:Renal Insufficiency, Chronic / Q000097:blood; D020521:Stroke / Q000097:blood; D018487:Ventricular Dysfunction, Left / Q000097:blood* / Q000175:diagnosis
chemical_list: D015415:Biomarkers; D020097:Natriuretic Peptide, Brain